US Patent 10301646 Nuclease-mediated targeting with large targeting vectors
Patent 10301646 was granted and assigned to Regeneron Pharmaceuticals on May, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10301646 Nuclease-mediated targeting with large targeting vectors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
